Skip to main content
رجوع
Watch Compare

ONCOLYTICS BIOTECH INC

جودة البيانات: 83%
ONCY
NASDAQ Manufacturing Chemicals
KWD 1.02
▼ KWD 0.03 (-2.86%)
6 months return
—
Momentum
Neutral
Free cash flow
-20.12 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROIC-1532.26%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio1.12
Interest CoverageN/A

التقييم

PE (TTM|NTM)
-4.12 | -2.76
أقل من متوسط القطاع (-1.50)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -20.12 M

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

6 محللين
Buy
+398.9%
upside to target
الحالي
KWD 1.02
Consensus Target
KWD 5.09
KWD 2.93
أدنى
KWD 9.98
أعلى
التوقعات
مكرر الربحية المستقبلي
-2.76
ربحية السهم المستقبلية
-KWD 0.34
الإيرادات المقدّرة
0.0

مفاجآت الأرباح

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -KWD 0.07 · Rev Est: 0.0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -KWD 0.08 -KWD 0.07 -KWD 0.14 — — —
Estimate -KWD 0.09 -KWD 0.08 -KWD 0.07 -KWD 0.09 -KWD 0.07 -KWD 0.08
المفاجأة +11.11% +17.33% -108.18% — — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -28.76 M
ROE N/A ROA -379.31%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -20.12 M
ROIC -1532.26% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 1.12
Debt / Equity N/A Current Ratio 1.12
Interest Coverage N/A Asset Turnover N/A
Working Capital 743,000 Tangible Book Value -3.80 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -4.12 · EV/EBITDA: N/A
P/E Ratio -4.12 Forward P/E -2.76
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -16.98%
Market Cap 118.45 M Enterprise Value 113.25 M

Per Share

EPS: -0.30 · FCF/Share: -0.17
EPS (Diluted TTM) -0.30 Revenue / Share N/A
FCF / Share -0.17 OCF / Share -0.17
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 69.95% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 69.95%
SBC-Adj. FCF -23.22 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue —
Net Income -28.76 M
EPS (Diluted) -0.30
Gross Profit —
Operating Income -28.73 M
EBITDA —
R&D Expenses 13.31 M
SG&A Expenses —
D&A —
Interest Expense —
Income Tax 79,000.0

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 7.58 M
Total Liabilities 11.38 M
Shareholders' Equity -3.80 M
Total Debt —
Cash & Equivalents 5.20 M
Current Assets 6.84 M
Current Liabilities 6.10 M

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E -4.1 -1.5
P/B — 1.6
ROE % — -54.7
Net Margin % — -41.5
Rev Growth 5Y % — 1.7
D/E — 0.3